Literature DB >> 30718083

Advances in the Development of Anti-Toxoplasma gondii Vaccines: Challenges, Opportunities, and Perspectives.

Jin-Lei Wang1, Nian-Zhang Zhang1, Ting-Ting Li1, Jun-Jun He1, Hany M Elsheikha2, Xing-Quan Zhu3.   

Abstract

Important progress has been made in understanding how immunity is elicited against Toxoplasma gondii - a complex pathogen with multiple mechanisms of immune evasion. Many vaccine candidates have been tested using various strategies in animal models. However, none of these strategies has delivered as yet, and important challenges remain in the development of vaccines that can eliminate the tissue cysts and/or fully block vertical transmission. In this review, we provide an overview of the current understanding of the host immune response to T. gondii infection and summarize the key limitations for the development of an effective, safe, and durable toxoplasmosis vaccine. We also discuss how the successes and failures in developing and testing vaccine candidates have provided a roadmap for future vaccine development.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Toxoplasma gondii; challenges; omics; protective efficacy; vaccination; vaccines

Mesh:

Substances:

Year:  2019        PMID: 30718083     DOI: 10.1016/j.pt.2019.01.005

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  25 in total

Review 1.  Epidemiology, Pathophysiology, Diagnosis, and Management of Cerebral Toxoplasmosis.

Authors:  Hany M Elsheikha; Christina M Marra; Xing-Quan Zhu
Journal:  Clin Microbiol Rev       Date:  2020-11-25       Impact factor: 26.132

Review 2.  PLGA Nanoparticles as an Efficient Platform in Protein Vaccines Against Toxoplasma gondii.

Authors:  Mojgan Allahyari
Journal:  Acta Parasitol       Date:  2022-01-11       Impact factor: 1.440

3.  MicroRNA-155 contributes to host immunity against Toxoplasma gondii.

Authors:  Yanan Xu; Junhua Wu; Xiaoqi Yuan; Wenyuan Liu; Jiewen Pan; Binbin Xu
Journal:  Parasite       Date:  2021-12-15       Impact factor: 3.000

Review 4.  REVIEW OF DNA VACCINE APPROACHES AGAINST THE PARASITE TOXOPLASMA GONDII.

Authors:  Rosalie C Warner; Ryan C Chapman; Brianna N Davis; Paul H Davis
Journal:  J Parasitol       Date:  2021-11-01       Impact factor: 1.276

5.  1,3,4-Thiadiazoles Effectively Inhibit Proliferation of Toxoplasma gondii.

Authors:  Lidia Węglińska; Adrian Bekier; Katarzyna Dzitko; Barbara Pacholczyk-Sienicka; Łukasz Albrecht; Tomasz Plech; Piotr Paneth; Agata Paneth
Journal:  Cells       Date:  2021-04-29       Impact factor: 6.600

Review 6.  Advances in Toxoplasma gondii Vaccines: Current Strategies and Challenges for Vaccine Development.

Authors:  Ki-Back Chu; Fu-Shi Quan
Journal:  Vaccines (Basel)       Date:  2021-04-21

Review 7.  Vaccines in Congenital Toxoplasmosis: Advances and Perspectives.

Authors:  Mariana Barros; Daniela Teixeira; Manuel Vilanova; Alexandra Correia; Natercia Teixeira; Margarida Borges
Journal:  Front Immunol       Date:  2021-02-15       Impact factor: 7.561

Review 8.  Catastrophic consequences: can the feline parasite Toxoplasma gondii prompt the purrfect neuroinflammatory storm following traumatic brain injury?

Authors:  Tamara L Baker; Mujun Sun; Bridgette D Semple; Shiraz Tyebji; Christopher J Tonkin; Richelle Mychasiuk; Sandy R Shultz
Journal:  J Neuroinflammation       Date:  2020-07-25       Impact factor: 8.322

9.  Virus-like particles containing multiple antigenic proteins of Toxoplasma gondii induce memory T cell and B cell responses.

Authors:  Su-Hwa Lee; Ki-Back Chu; Hae-Ji Kang; Fu-Shi Quan
Journal:  PLoS One       Date:  2019-08-29       Impact factor: 3.240

Review 10.  Use of Veterinary Vaccines for Livestock as a Strategy to Control Foodborne Parasitic Diseases.

Authors:  Valeria A Sander; Edwin F Sánchez López; Luisa Mendoza Morales; Victor A Ramos Duarte; Mariana G Corigliano; Marina Clemente
Journal:  Front Cell Infect Microbiol       Date:  2020-06-26       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.